Brainstorm Cell Therapeutics reported $8.95M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adamis Pharmaceuticals ADMP:US USD 8.87M 850.2K
Biogen BIIB:US USD 3.93B 1.09B
Brainstorm Cell Therapeutics BCLI:US USD 8.95M 1.1M
Cytokinetics CYTK:US USD 76.5M 9.65M
Gilead Sciences GILD:US USD 10.42B 1.2B
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Idera Pharmaceuticals IDRA:US USD 19.23M 14.5M